Mexico Clears $12B Nestle-Pfizer Deal After Divestiture

Law360, New York (April 15, 2013, 5:06 PM EDT) -- Mexico's antitrust agency has reached a deal with Nestle SA allowing it to sell Pfizer Inc.'s Mexican infant formula business to a third party, removing one of the last roadblocks in the way of Nestle finalizing its $11.85 billion acquisition of Pfizer's global infant nutrition unit, the watchdog announced Monday.

According to the Federal Competition Commission, or CFC, its five-member board voted unanimously to allow Nestle to sell Pfizer’s Mexican unit to a third party, as well as giving an exclusive license to that company to...
To view the full article, register now.